These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 870233)

  • 81. The effect of the converting enzyme inhibitor SQ 20.881 on kinins, renin-angiotensin-aldosterone and catecholamines in relation to blood pressure in hypertensive patients.
    Hulthén L; Hökfelt B
    Acta Med Scand; 1978; 204(6):497-502. PubMed ID: 735881
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Effects of converting enzyme inhibitor (SQ 20881) on changes in blood pressure and plasma aldosterone induced by angiotensin I or acute hemorrhage in rabbits.
    Saito I; Eguchi T; Nakamura R; Misumi J; Kondo K; Saruta T
    Jpn Heart J; 1980 Jan; 21(1):95-101. PubMed ID: 6154159
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Graded dose effects of angiotensin II on aldosterone production in man during various levels of potassium intake.
    Linde R; Winn S; Latta D; Hollifield J
    Metabolism; 1981 Jun; 30(6):549-53. PubMed ID: 7231191
    [TBL] [Abstract][Full Text] [Related]  

  • 84. [Effects of coenzyme Q on plasma aldosterone concentrations in dogs (author's transl)].
    Tahira H
    Nihon Naibunpi Gakkai Zasshi; 1976 Feb; 52(2):125-37. PubMed ID: 987937
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Studies of the control of plasma aldosterone concentration in normal man. II. Effect of dietary potassium and acute potassium infusion.
    Dluhy RG; Axelrod L; Underwood RH; Williams GH
    J Clin Invest; 1972 Aug; 51(8):1950-7. PubMed ID: 5054456
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Reciprocal changes in active and inactive renin after converting enzyme inhibition in normal man.
    Goldstone R; Horton R; Carlson EJ; Hsueh WA
    J Clin Endocrinol Metab; 1983 Feb; 56(2):264-8. PubMed ID: 6296183
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Converting enzyme inhibition in essential hypertension: the hypotensive response does not reflect only reduced angiotensin II formation.
    Swartz SL; Williams GH; Hollenberg NK; Moore TJ; Dluhy RG
    Hypertension; 1979; 1(2):106-11. PubMed ID: 233366
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Insulin influences the renin-angiotensin-aldosterone system in humans.
    Trovati M; Massucco P; Anfossi G; Cavalot F; Mularoni E; Mattiello L; Rocca G; Emanuelli G
    Metabolism; 1989 Jun; 38(6):501-3. PubMed ID: 2542723
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Role of the renin-angiotensin system in potassium control.
    Young DB; McCaa RE
    Am J Physiol; 1980 May; 238(5):R359-63. PubMed ID: 6990795
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Familial hyperpotassemia and hypertension accompanied by normal plasma aldosterone levels: possible hereditary cell membrane defect.
    Farfel Z; Iaina A; Rosenthal T; Waks U; Shibolet S; Gafni J
    Arch Intern Med; 1978 Dec; 138(12):1828-32. PubMed ID: 718348
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Angiotensin II/aldosterone dose-response curves in the dog: effect of changes in sodium balance.
    Nicholls MG; Tree M; Brown JJ; Douglas BH; Fraser R; Hay GD; Lever AF; Morton JJ; Robertson JI
    Endocrinology; 1978 Feb; 102(2):485-93. PubMed ID: 743970
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Effect of plasma sodium on aldosterone secretion during angiotensin II stimulation in normal humans.
    Merrill DC; Ebert TJ; Skelton MM; Cowley AW
    Hypertension; 1989 Aug; 14(2):164-9. PubMed ID: 2527200
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Relationship between plasma aldosterone and angiotensin II before and after noradrenergic inhibition in normal subjects and patients with mild essential hypertension.
    Beretta-Piccoli C; Weidmann P; Boehringer K; Link L; Bianchetti MG; Morton JJ
    J Clin Endocrinol Metab; 1984 Aug; 59(2):316-20. PubMed ID: 6736206
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Renin suppression by saline is blunted in nonmodulating essential hypertension.
    Rabinowe SL; Redgrave JE; Shoback DM; Podolsky S; Hollenberg NK; Williams GH
    Hypertension; 1987 Oct; 10(4):404-8. PubMed ID: 3308701
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Aldosterone responses to angiotensin II, adrenocorticotropin, and potassium in chronic experimental diabetes mellitus in rats.
    Hayashi M; Kitajima W; Saruta T
    Endocrinology; 1984 Dec; 115(6):2205-9. PubMed ID: 6094152
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Angiotensin II induces the release of 19-hydroxyandrostenedione in man.
    Sekihara H; Torii R; Osawa Y; Takaku F
    J Clin Endocrinol Metab; 1985 Aug; 61(2):291-6. PubMed ID: 2989318
    [TBL] [Abstract][Full Text] [Related]  

  • 97. The influence of potassium on the renal vasculature and the adrenal gland, and their responsiveness to angiotensin II in normal man.
    Hollenberg NK; Williams G; Burger B; Hooshmand I
    Clin Sci Mol Med; 1975 Dec; 49(6):527-34. PubMed ID: 1204282
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Hyperreninemic hypoaldosteronism in the critically ill: a new entity.
    Zipser RD; Davenport MW; Martin KL; Tuck ML; Warner NE; Swinney RR; Davis CL; Horton R
    J Clin Endocrinol Metab; 1981 Oct; 53(4):867-73. PubMed ID: 6270176
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Role of angiotensin II in potassium-mediated stimulation of aldosterone secretion in the dog.
    Pratt JH
    J Clin Invest; 1982 Sep; 70(3):667-72. PubMed ID: 6286729
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Renin-angiotensin II-aldosterone and ACTH-cortisol control during acute hypoxemia and exercise in patients with chronic obstructive pulmonary disease.
    Raff H; Levy SA
    Am Rev Respir Dis; 1986 Mar; 133(3):396-9. PubMed ID: 3006560
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.